PRESS RELEASE published on 06/23/2025 at 07:00, 1 year 4 months ago Communiqué de presse : Sarclisa recommandé pour approbation dans l’UE par le CHMP pour le traitement du myélome multiple nouvellement diagnostiqué chez les patients éligibles à une greffe Sarclisa recommandé pour approbation dans l’UE par le CHMP pour le traitement du myélome multiple. Recommandation basée sur l'étude de phase 3 GMMG-HD7 montrant amélioration significative de la SSP Myélome Multiple Approbation Sarclisa CHMP GMMG-HD7
BRIEF published on 06/20/2025 at 07:05, 1 year 4 months ago FDA Approves Dupixent for Bullous Pemphigoid Treatment FDA Approval Dupixent Type 2 Inflammation Bullous Pemphigoid Rare Skin Disease
BRIEF published on 06/20/2025 at 07:05, 1 year 4 months ago La FDA approuve le Dupixent pour le traitement de la pemphigoïde bulleuse Approbation De La FDA Dupixent Pemphigoïde Bulleuse Inflammation De Type 2 Maladie Cutanée Rare
PRESS RELEASE published on 06/20/2025 at 07:00, 1 year 4 months ago Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid Dupixent approved in the US as the only targeted medicine for bullous pemphigoid, meeting the critical treatment needs of patients with uncontrolled disease FDA Approval Chronic Disease Dupixent Type 2 Inflammation Bullous Pemphigoid
PRESS RELEASE published on 06/20/2025 at 07:00, 1 year 4 months ago Communiqué de presse : Dupixent est approuvé aux États-Unis comme le seul médicament ciblé pour traiter les patients atteints de pemphigoïde bulleuse Dupixent approuvé par la FDA aux États-Unis pour traiter la pemphigoïde bulleuse, offrant une nouvelle approche ciblée contre l'inflammation de type 2. Résultats positifs de l'étude ADEPT FDA Dupixent Pemphigoïde Bulleuse Inflammation De Type 2 Étude ADEPT
BRIEF published on 06/17/2025 at 13:45, 1 year 4 months ago Sanofi Successfully Prices €1.5 Billion Bond Issue Bond Issue Corporate Financing Sanofi Fixed-rate Notes Euro Medium Term Note
BRIEF published on 06/17/2025 at 13:45, 1 year 4 months ago Sanofi fixe avec succès le prix d'une émission obligataire de 1,5 milliard d'euros Emission D'obligations Sanofi Financement Des Entreprises Obligations À Taux Fixe Billet À Moyen Terme En Euros
PRESS RELEASE published on 06/17/2025 at 13:40, 1 year 4 months ago Press release: Sanofi successfully prices €1.5 billion bond issue Sanofi successfully prices €1.5 billion bond issue with fixed-rate notes across 2 tranches, using proceeds for general corporate purposes, led by Citigroup and RBC Capital Markets, under Euro Medium Term Note Programme Financial Markets Bond Issue Sanofi Euro Medium Term Note Programme Fixed-rate Notes
PRESS RELEASE published on 06/17/2025 at 13:40, 1 year 4 months ago Communiqué de presse : Sanofi place 1,5 milliard d’euros d’emprunts obligataires Sanofi place 1,5 milliard d’euros d’emprunts obligataires avec succès pour financer ses besoins généraux. Citigroup et RBC Capital Markets ont agi en tant que coordinateurs Sanofi Citigroup RBC Capital Markets Emprunts Obligataires Besoins Généraux
PRESS RELEASE published on 06/16/2025 at 22:40, 1 year 4 months ago Sanofi : Déclaration des transactions sur actions propres
Published on 11/05/2026 at 15:20, 6 hours 28 minutes ago MicroVision and LAKE FUSION Technologies Sign Multi-Year Strategic Partnership Agreement for IRIS(TM) Lidar Sensors
Published on 11/05/2026 at 14:31, 7 hours 17 minutes ago First Breach Close-Quarters Strike (CQS) Drone Successfully Completes Full Mission Profile
Published on 11/05/2026 at 14:25, 7 hours 23 minutes ago Polaris Renewable Energy Announces Q3 2026 Results
Published on 11/05/2026 at 14:20, 7 hours 28 minutes ago Polaris Renewable Energy Declares Quarterly Dividend
Published on 11/05/2026 at 14:15, 7 hours 33 minutes ago Loar Holdings Inc. Reports Q3 2026 Record Results and Upward Revision to 2026 Outlook and Full Year 2027 Outlook
Published on 11/05/2026 at 20:38, 1 hour 9 minutes ago freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 1 hour 10 minutes ago EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 2 hours 2 minutes ago Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets
Published on 11/05/2026 at 19:41, 2 hours 6 minutes ago EQS-Adhoc: Stabilus SE – Around €67 million in non-cash impairments reduce EBIT for FY2026; Preliminary Q4 FY2026 figures: Revenue and adjusted EBIT exceed market expectations, while adjusted free cash flow fall
Published on 11/05/2026 at 18:21, 3 hours 26 minutes ago Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 3 hours 26 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026